Editas Medicine Supports Global Movement to Raise Awareness on Rare Disease Day®

Editas Medicine Announces Fourth Quarter and Full Year 2018 Results and Update

Jounce Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Wednesday, March 6, 2019

Maze Therapeutics Launches with $191 Million to Focus on Translating Genetic Insights into New Medicines

MyoKardia Reports Fourth Quarter and Full Year 2018 Financial Results